BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Contract Services

WuXi Biologics to Increase Manufacturing Capacity in Germany

- The investment promotes the creation of additional high-skilled jobs - As part of WuXi Biologics' global manufacturing network, a new drug p...

June 02, 2023 | News

Catalent Enhances Cryogenic Capabilities in Japan Facility for Cell and Gene Therapy Development

State-of-the-art cryogenic freezers alongside material transfer equipment have been installed that are designed to retain the integrity of investigational ...

May 25, 2023 | News

WuXi Biologics Receives 2023 ISPE Facility of the Year Award for Operations

The awarded facility includes two manufacturing areas utilizing 6x1KL single-use bioreactors for perfusion and 12x4KL single-use bioreactors for fed-batch,...

May 23, 2023 | News

Australia's First End-to-End mRNA CDMO Facility to Boost Vaccine Production and Research Capabilities

What is the significance of the first end-to-end mRNA process contract development and manufacturing organization (CDMO) establishment in Australia? ...

May 17, 2023 | News

Vetter Expands Production Capacities and Services Offered at Its Austrian Site

Vetter, a leading global Contract Development and Manufacturing Organization (CDMO), continues to drive the expansion of capacities and services for the pr...

May 09, 2023 | News

Exothera Forms Partnership with Quantoom Biosciences to Launch RNA Business Unit

Exothera has partnered with Quantoom Biosciences ("Quantoom") to gain access to Quantoom’s Nfinity technology, a continuous production platform for R...

April 27, 2023 | News

Cytiva supports BioCina with first GMP production and development facility for mRNA in Australia

Expanded facility to manufacture mRNA-based therapies and vaccines Researchers at the University of Adelaide will address the design and ma...

April 26, 2023 | News

OBiO Technology Launches New Super Factory in Shanghai with 29 GMP-Grade Production Lines for Gene and Cell Therapy

At the opening ceremony, OBiO showed the holistic process development capability and large-scale GMP manufacturing capacity in variety gene and cell therap...

April 25, 2023 | News

Excelra Acquires BISC Global, Forming International Bioinformatics Powerhouse

Excelra is a trusted partner to the world's top pharmaceutical and biotechnology companies, providing data, insight, and R&D technology services. Its i...

April 21, 2023 | News

Crystal Formulation Services Receives China Drug Manufacturing License for Milestone Formulation Capability

Crystal Formulation Services, a subsidiary of Crystal Pharmatech, has achieved an exciting new milestone in its formulation capabilities. The company was r...

April 20, 2023 | News

Anixa Biosciences and Cleveland Clinic Present Positive Data for Phase 1 Study of Breast Cancer Vaccine

Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer announced that Clev...

April 18, 2023 | News

Bone Biologics Gets Approval for Pilot Clinical Trial with NB1 for Spinal Fusion in Australia.

Bone Biologics Corporation (NASDAQ: BBLG), a developer of orthobiologic products for spine fusion markets, announces that the Human Research Ethics Committ...

April 13, 2023 | News

Bora Pharmaceuticals and Celltrion Partners to Expand OSD capabilities in APAC market

The range of oral dosage form products will be manufactured at Bora’s Zhunan Site, which is one of the largest US FDA and MHRA-approved pharmaceutica...

April 10, 2023 | News

Catalent builds $20M expansion for German clinical supply facility

Catalent, the leader in enabling the development and supply of better treatments for patients worldwide, today announced that it has begun construction of ...

April 06, 2023 | News

Stay Connected